(Q40957417)

English

Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation

scientific article published on May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation (English)

1 reference

Europe PubMed Central

25 September 2017

oligosaccharide

1 reference

based on heuristic

inferred from title

author name string

Pye DA

1

1 reference

Europe PubMed Central

25 September 2017

Gallagher JT

2

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

25 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

25 September 2017

274

1 reference

Europe PubMed Central

25 September 2017

13456-13461

1 reference

Europe PubMed Central

25 September 2017

19

1 reference

Europe PubMed Central

25 September 2017

Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structure and expression of a novel fibroblast growth factor, FGF-17, preferentially expressed in the embryonic brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

The heparin-binding (fibroblast) growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

The ins and outs of fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Angiogenic factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Inhibitors of angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Heparin structure and interactions with basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Receptor- and heparin-binding domains of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Nature of the interaction of heparin with acidic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Molecular organization of the interferon gamma-binding domain in heparan sulphate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Molecular attributes of bovine aortic endothelial cell heparan sulfate.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

A dual receptor system is required for basic fibroblast growth factor activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Dimerization of cell surface receptors in signal transduction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Characterization of a cysteine-free analog of recombinant human basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Proteoglycans: structures and interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

An essential heparin-binding domain in the fibroblast growth factor receptor kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Zero-length crosslinking procedure with the use of active esters

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Stabilizing basic fibroblast growth factor using protein engineering

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13456

21 January 2018

Identifiers

10.1074/JBC.274.19.13456

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40957417&oldid=1911135146"